Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Genetic counselling in a national referral centre for pulmonary hypertension.

Girerd B, Montani D, Jaïs X, Eyries M, Yaici A, Sztrymf B, Savale L, Parent F, Coulet F, Godinas L, Lau EM, Tamura Y, Sitbon O, Soubrier F, Simonneau G, Humbert M.

Eur Respir J. 2016 Feb;47(2):541-52. doi: 10.1183/13993003.00717-2015. Epub 2015 Dec 23.

2.

Proinflammatory cytokine levels are linked to death in pulmonary arterial hypertension.

Cracowski JL, Chabot F, Labarère J, Faure P, Degano B, Schwebel C, Chaouat A, Reynaud-Gaubert M, Cracowski C, Sitbon O, Yaici A, Simonneau G, Humbert M.

Eur Respir J. 2014 Mar;43(3):915-7. doi: 10.1183/09031936.00151313. Epub 2013 Nov 14. No abstract available.

3.

Factors associated with diagnosis and operability of chronic thromboembolic pulmonary hypertension. A case-control study.

Lang IM, Simonneau G, Pepke-Zaba JW, Mayer E, Ambrož D, Blanco I, Torbicki A, Mellemkjaer S, Yaici A, Delcroix M.

Thromb Haemost. 2013 Jul;110(1):83-91. doi: 10.1160/TH13-02-0097. Epub 2013 May 16.

PMID:
23677493
4.

Independent association of urinary F2-isoprostanes with survival in pulmonary arterial hypertension.

Cracowski JL, Degano B, Chabot F, Labarère J, Schwedhelm E, Monneret D, Iuliano L, Schwebel C, Chaouat A, Reynaud-Gaubert M, Faure P, Maas R, Renversez JC, Cracowski C, Sitbon O, Yaïci A, Simonneau G, Humbert M.

Chest. 2012 Oct;142(4):869-876. doi: 10.1378/chest.11-1267.

PMID:
22406961
5.

IgG from patients with pulmonary arterial hypertension and/or systemic sclerosis binds to vascular smooth muscle cells and induces cell contraction.

Bussone G, Tamby MC, Calzas C, Kherbeck N, Sahbatou Y, Sanson C, Ghazal K, Dib H, Weksler BB, Broussard C, Verrecchia F, Yaici A, Witko-Sarsat V, Simonneau G, Guillevin L, Humbert M, Mouthon L.

Ann Rheum Dis. 2012 Apr;71(4):596-605. doi: 10.1136/annrheumdis-2011-200195. Epub 2011 Nov 14.

PMID:
22084393
6.

Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival.

Humbert M, Yaici A, de Groote P, Montani D, Sitbon O, Launay D, Gressin V, Guillevin L, Clerson P, Simonneau G, Hachulla E.

Arthritis Rheum. 2011 Nov;63(11):3522-30. doi: 10.1002/art.30541.

7.

A hemodynamic study of pulmonary hypertension in sickle cell disease.

Parent F, Bachir D, Inamo J, Lionnet F, Driss F, Loko G, Habibi A, Bennani S, Savale L, Adnot S, Maitre B, Yaïci A, Hajji L, O'Callaghan DS, Clerson P, Girot R, Galacteros F, Simonneau G.

N Engl J Med. 2011 Jul 7;365(1):44-53. doi: 10.1056/NEJMoa1005565.

8.

Endothelin receptor antagonists for the treatment of pulmonary arterial hypertension.

O'Callaghan DS, Savale L, Yaïci A, Natali D, Jaïs X, Parent F, Montani D, Humbert M, Simonneau G, Sitbon O.

Expert Opin Pharmacother. 2011 Jul;12(10):1585-96. doi: 10.1517/14656566.2011.564159. Epub 2011 Apr 20. Review.

PMID:
21504371
9.

Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease.

Launay D, Humbert M, Berezne A, Cottin V, Allanore Y, Couderc LJ, Bletry O, Yaici A, Hatron PY, Mouthon L, Le Pavec J, Clerson P, Hachulla E.

Chest. 2011 Oct;140(4):1016-1024. doi: 10.1378/chest.10-2473. Epub 2011 Apr 7.

PMID:
21474572
10.

Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era.

Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaïci A, Weitzenblum E, Cordier JF, Chabot F, Dromer C, Pison C, Reynaud-Gaubert M, Haloun A, Laurent M, Hachulla E, Cottin V, Degano B, Jaïs X, Montani D, Souza R, Simonneau G.

Circulation. 2010 Jul 13;122(2):156-63. doi: 10.1161/CIRCULATIONAHA.109.911818. Epub 2010 Jun 28.

PMID:
20585011
11.

Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension.

Humbert M, Sitbon O, Yaïci A, Montani D, O'Callaghan DS, Jaïs X, Parent F, Savale L, Natali D, Günther S, Chaouat A, Chabot F, Cordier JF, Habib G, Gressin V, Jing ZC, Souza R, Simonneau G; French Pulmonary Arterial Hypertension Network.

Eur Respir J. 2010 Sep;36(3):549-55. doi: 10.1183/09031936.00057010. Epub 2010 Jun 18.

12.

Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension.

Girerd B, Montani D, Eyries M, Yaici A, Sztrymf B, Coulet F, Sitbon O, Simonneau G, Soubrier F, Humbert M.

Respir Res. 2010 Jun 10;11:73. doi: 10.1186/1465-9921-11-73.

13.

Pulmonary veno-occlusive disease: recent progress and current challenges.

Montani D, O'Callaghan DS, Savale L, Jaïs X, Yaïci A, Maitre S, Dorfmuller P, Sitbon O, Simonneau G, Humbert M.

Respir Med. 2010 Jul;104 Suppl 1:S23-32. doi: 10.1016/j.rmed.2010.03.014. Epub 2010 Apr 24. Review.

14.

Pulmonary arterial hypertension associated with systemic sclerosis in patients with functional class II dyspnoea: mild symptoms but severe outcome.

Hachulla E, Launay D, Yaici A, Berezne A, de Groote P, Sitbon O, Mouthon L, Guillevin L, Hatron PY, Simonneau G, Clerson P, Humbert M; French PAH-SSc Network.

Rheumatology (Oxford). 2010 May;49(5):940-4. doi: 10.1093/rheumatology/kep449. Epub 2010 Feb 8.

PMID:
20144930
15.

Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation.

Girerd B, Montani D, Coulet F, Sztrymf B, Yaici A, Jaïs X, Tregouet D, Reis A, Drouin-Garraud V, Fraisse A, Sitbon O, O'Callaghan DS, Simonneau G, Soubrier F, Humbert M.

Am J Respir Crit Care Med. 2010 Apr 15;181(8):851-61. doi: 10.1164/rccm.200908-1284OC. Epub 2010 Jan 7.

PMID:
20056902
16.

Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil.

Launay D, Sitbon O, Le Pavec J, Savale L, Tchérakian C, Yaïci A, Achouh L, Parent F, Jais X, Simonneau G, Humbert M.

Rheumatology (Oxford). 2010 Mar;49(3):490-500. doi: 10.1093/rheumatology/kep398. Epub 2009 Dec 16.

PMID:
20015974
17.

HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era.

Degano B, Guillaume M, Savale L, Montani D, Jaïs X, Yaici A, Le Pavec J, Humbert M, Simonneau G, Sitbon O.

AIDS. 2010 Jan 2;24(1):67-75. doi: 10.1097/QAD.0b013e328331c65e.

PMID:
19770696
18.

Therapeutic advances in pulmonary arterial hypertension.

Boutet K, Montani D, Jaïs X, Yaïci A, Sitbon O, Simonneau G, Humbert M.

Ther Adv Respir Dis. 2008 Aug;2(4):249-65. doi: 10.1177/1753465808094762. Review.

PMID:
19124376
19.

Pulmonary veno-occlusive disease.

Montani D, Price LC, Dorfmuller P, Achouh L, Jaïs X, Yaïci A, Sitbon O, Musset D, Simonneau G, Humbert M.

Eur Respir J. 2009 Jan;33(1):189-200. doi: 10.1183/09031936.00090608. Review.

20.

Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension.

Degano B, Yaïci A, Le Pavec J, Savale L, Jaïs X, Camara B, Humbert M, Simonneau G, Sitbon O.

Eur Respir J. 2009 Jan;33(1):92-8. doi: 10.1183/09031936.00094808. Epub 2008 Sep 17.

21.

Portopulmonary hypertension: survival and prognostic factors.

Le Pavec J, Souza R, Herve P, Lebrec D, Savale L, Tcherakian C, Jaïs X, Yaïci A, Humbert M, Simonneau G, Sitbon O.

Am J Respir Crit Care Med. 2008 Sep 15;178(6):637-43. doi: 10.1164/rccm.200804-613OC. Epub 2008 Jul 10.

PMID:
18617641
22.

Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.

Sztrymf B, Coulet F, Girerd B, Yaici A, Jais X, Sitbon O, Montani D, Souza R, Simonneau G, Soubrier F, Humbert M.

Am J Respir Crit Care Med. 2008 Jun 15;177(12):1377-83. doi: 10.1164/rccm.200712-1807OC. Epub 2008 Mar 20.

PMID:
18356561
23.

Identification of target antigens of antifibroblast antibodies in pulmonary arterial hypertension.

Terrier B, Tamby MC, Camoin L, Guilpain P, Broussard C, Bussone G, Yaïci A, Hotellier F, Simonneau G, Guillevin L, Humbert M, Mouthon L.

Am J Respir Crit Care Med. 2008 May 15;177(10):1128-34. doi: 10.1164/rccm.200707-1015OC. Epub 2008 Feb 14.

PMID:
18276943
24.

Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases.

Jais X, Launay D, Yaici A, Le Pavec J, Tchérakian C, Sitbon O, Simonneau G, Humbert M.

Arthritis Rheum. 2008 Feb;58(2):521-31. doi: 10.1002/art.23303.

25.

Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases.

Souza R, Humbert M, Sztrymf B, Jaïs X, Yaïci A, Le Pavec J, Parent F, Hervé P, Soubrier F, Sitbon O, Simonneau G.

Eur Respir J. 2008 Feb;31(2):343-8. Epub 2007 Oct 24. Erratum in: Eur Respir J. 2008 Apr;31(4):912.

26.

[Pulmonary arterial hypertension due to tumor emboli].

Dot JM, Sztrymf B, Yaïci A, Dorfmüller P, Capron F, Parent F, Jaïs X, Sitbon O, Simonneau G, Humbert M.

Rev Mal Respir. 2007 Mar;24(3 Pt 1):359-66. French.

PMID:
17417176
27.

Genes and pulmonary arterial hypertension.

Sztrymf B, Yaïci A, Girerd B, Humbert M.

Respiration. 2007;74(2):123-32. Review.

PMID:
17318011
28.

Idiopathic pulmonary hypertension: what did we learn from genes?

Sztrymf B, Yaïci A, Jaïs X, Sitbon O, Simonneau G, Humbert M.

Sarcoidosis Vasc Diffuse Lung Dis. 2005 Dec;22 Suppl 1:S91-100. Review.

PMID:
16457021
29.

Pulmonary arterial hypertension in France: results from a national registry.

Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaici A, Weitzenblum E, Cordier JF, Chabot F, Dromer C, Pison C, Reynaud-Gaubert M, Haloun A, Laurent M, Hachulla E, Simonneau G.

Am J Respir Crit Care Med. 2006 May 1;173(9):1023-30. Epub 2006 Feb 2.

PMID:
16456139
30.

Clinical challenges in pulmonary hypertension: Roger S. Mitchell lecture.

Provencher S, Jais X, Yaici A, Sitbon O, Humbert M, Simonneau G.

Chest. 2005 Dec;128(6 Suppl):622S-628S. Review.

PMID:
16373880
31.

[Genetics of pulmonary arterial hypertension: recent data and practical applications].

Sztrymf B, Yaici A, Jaïs X, Simonneau G, Sitbon O, Humbert M.

Rev Mal Respir. 2005 Nov;22(5 Pt 1):796-805. Review. French.

PMID:
16272982
32.

[Biomarkers as prognostic factors in pulmonary arterial hypertension. Rationale and study design].

Cracowski JL, Yaici A, Sitbon O, Reynaud-Gaubert M, Renversez JC, Pison C, Faure P, Cracowski C, Chouri N, Chaouat A, Chabot F, Schwedhelm E, Maas R, Degano B, Mornex JF, Humbert M.

Rev Mal Respir. 2004 Dec;21(6 Pt 1):1137-43. French.

PMID:
15767959
33.

[Pulmonary hypertension: from genetics to treatments].

Humbert M, Yaïci A, Sztrymf B, Montani D.

Rev Pneumol Clin. 2004 Sep;60(4):196-201. Review. French.

PMID:
15545947
34.

[Pulmonary arterial hypertension].

Montani D, Hamid A, Yaïci A, Sztrymf B, Humbert M.

Rev Prat. 2004 Jan 15;54(1):5-13. Review. French.

PMID:
15049592
35.

[Sympathomimetic amines in cardiac intensive care].

Renard M, Caraballo C, Yaici A, Vainsel H, Bernard R.

Rev Med Brux. 1982 Dec;3(10):729-31. French. No abstract available.

PMID:
6131524

Supplemental Content

Support Center